SweetValueLab
Write for us

Danaher Corporation — Intrinsic Value & Fair Price

DHR
NYSEHealthcareMedical - Diagnostics & ResearchCIK 0000313616danaher.comAbout DHR
Last close · Oct 16, 2026229.04−2.46 (−1.06%)
Market cap$161.0B
Model value · DCF · Perpetuity growth · 5y
143.75
Danaher closed at $229.04 — overvalued by 59% vs model.
88.59the model's range346.91

DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
34.78 – 249.09
Wall St. target
240.00 5% below
Above model, 1y
21 of 21 days

Price and model value

Embed this card

DHR's close against its model value, as a 420×168 card for your own page. It updates nightly with this site and links back here.

Free to embed; keep the attribution link.
Loading chart…
What the marks mean
Daily close

Dividends

Quarterly · as of Oct 16, 2026
Yield, trailing 12 months
0.66%
Past 2 years
low 0.38%high 0.84%
Dividends per share, a year at a time
$0.72Sep ’21$0.85Sep ’22$0.97Oct ’23$1.05Sep ’24$1.23Sep ’25$1.52TTM
Dividends / free cash flow, FY2025
16.7%
Raised
12 years in a row
Growth, 5 yrs
16.2% a year
Last change
+25.0% · Mar 2026
Every payment, with ex-dates · latest $0.40, paid Oct 30, 2026

Research on DHR

No posts on DHR yet.
Studied DHR from its filings? Guest posts are reviewed before they go live.Write about DHR →

How it is valued

Valued asMature & Stable
Low/slowing growth (~1% recent)Moderate margins (15% net margin)Highly cyclical earnings
What growth the price implies: the reverse DCF

Key figures

FY2025
P/E
45.4×
EV / EBITDA
25.2×
FCF yield
3.2%
Dividend yield, TTM
0.66%
Beta
0.80
Cost of capital (WACC)
8.22%
Full financials

Analyst actions

third-party, quoted
10-12Morgan Stanley · target240.00
10-05RBC Capital · target250.00
10-01Guggenheim · target250.00
05-27Citigroup · “Neutral” from “Buy”downgrade
Ratings, targets and estimates

The weekly

One email a week across every stock we cover: 13F filings, insider trades, earnings and new research. It covers the whole market, not just DHR. No account.

About Danaher

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

CEO
Julie Sawyer Montgomery
Headquarters
Washington, DC
Employees
59,000
IPO
1978-12-29
Full company profile

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; the formulas are in how we value a stock.